Coronary revascularization in patients with coronary artery disease and chronic kidney disease

Advances in Chronic Kidney Disease
Ellen C Keeley, Peter A McCullough

Abstract

There is a remarkable lack of randomized trial data on optimal management of coronary artery disease (CAD) in patients with chronic kidney disease (CKD). In fact, patients with CKD are often excluded from randomized trials that compare different treatment strategies for CAD. Because the most common cause of death in CKD patients is cardiovascular disease, it is crucial that studies are designed to determine the best therapy for CAD in this high-risk group. This article discusses the available data on coronary revascularization outcomes in CKD patients.

References

Oct 1, 1988·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S G RostandA D Pacifico
Oct 1, 1988·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J A OpsahlA J Collins
Dec 1, 1986·The Annals of Thoracic Surgery·W G MarshallT Wedige-Stecher
Mar 1, 1996·Journal of Cardiac Surgery·L E SamuelsS K Brockman
Dec 24, 1997·Heart·M JahangiriP Magee
Sep 17, 1998·The New England Journal of Medicine·C A HerzogA J Collins
Nov 4, 1993·Journal of Interventional Cardiology·P T Vaitkus, S A Guidera
Jun 10, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G M ChertowB J McNeil
May 31, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J N BeattieP A McCullough
Mar 30, 2002·Journal of the American College of Cardiology·Patricia J M BestPeter B Berger
May 16, 2002·Circulation·L A SzczechUNKNOWN Bypass Angioplasty Revascularization Investigation (BARI) Investigators
Oct 2, 2002·Annals of Internal Medicine·R Scott WrightAllan S Jaffe
Feb 28, 2003·The Annals of Thoracic Surgery·Yoshihiro NakayamaTsuyoshi Itoh
Apr 16, 2003·The American Journal of the Medical Sciences·Christine M LogarSrinivasan Beddhu
Aug 26, 2003·Journal of the American Society of Nephrology : JASN·Donal N ReddanWilliam F Owen
Oct 29, 2003·Circulation·Mark J SarnakUNKNOWN American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology,

❮ Previous
Next ❯

Citations

May 11, 2005·Kidney International. Supplement·Peter A McCullough
Jan 25, 2012·Blood Purification·Peter A McCullough, Hadeel Assad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
S A Abraham, Kim A Eagle
Transplant International : Official Journal of the European Society for Organ Transplantation
J C WestR Latsha
© 2022 Meta ULC. All rights reserved